For the Inventor, By the Inventor

Enter inventor name

Boston, MA, United States of America

Diego A Gianolio

USPTO Granted Patents = 8 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 53(Granted Patents)

Location History:

Boston, MA (US) (2008)
Somerville, MA (US) (2017 - 2023)

Company Filing History:

Genzyme Corporation

Years Active: 2008-2024

Loading Chart...

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12110338 - Site-specific antibody-drug conjugation through glycoengineering (2024-10-08),

2. 11807690 - Hyperglycosylated binding polypeptides (2023-11-07),

3. 11130816 - Site-specific antibody-drug conjugation through glycoengineering (2021-09-28),

4. 10494439 - Hyperglycosylated binding polypeptides (2019-12-03),

5. 10214589 - Site-specific antibody-drug conjugation through glycoengineering (2019-02-26),

6. 9701753 - Hyperglycosylated binding polypeptides (2017-07-11),

7. 9580511 - Site-specific antibody-drug conjugation through glycoengineering (2017-02-28),

8. 7387836 - Aziridine compounds and their use in medical devices (2008-06-17),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…